GP120-W61D-107 is a variant fragment used to investigate structural motifs affected by charged-residue introduction at position 61. Its sequence supports analysis of protein-peptide interaction changes. Researchers examine folding behavior to assess epitope presentation. The molecule contributes to HIV envelope structural research.
CAT No: H09435
1. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
2. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
4. Emu oil in combination with other active ingredients for treating skin imperfections
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.